Neutralizing Monoclonal Antibodies in COVID-19 and Infusion Center Operations: Experiences and Insights Regarding Your Pressing Questions
register for 1 of 6 activities below
This Peer-to-Peer Clinical Connection series comprises 6 virtual live activities with interaction among expert clinicians, a facilitator, and an intimate audience of 8 to 12 invited clinicians, with simultaneous onscreen visibility available for all learners. Small-group interaction allows a direct connection with the expert as well as fellow learners for an intimate, in-depth clinical conversation that mirrors the networking and collaborative experience typically found in live local meetings. Video is encouraged by all participants.
Each hour-long session will be led by a team of experts, allowing each session discussion to be unique to the presenters and participants.
Faculty will review the role of monoclonal antibodies (mAbs) in the immune response for COVID-19; highlight the role of mAbs in the treatment of COVID-19; discuss the latest updates on mAb therapies for COVID-19; and strategies for optimizing infusion center operations. Register for 1 of the 6 events!
WEDNESDAY, JUNE 23, 2021 7:00 - 8:00 PM EDT
TUESDAY, JUNE 29, 2021 1:00 - 2:00 PM EDT
MONDAY, JUNE 28, 2021 7:00 - 8:00 PM EDT
WEDNESDAY, JUNE 30, 2021 1:00 - 2:00 PM EDT
MONDAY, JUNE 28, 2021
3:00 - 4:00 PM EDT
WEDNESDAY, JUNE 30, 2021
7:00 - 8:00 PM EDT
This activity is intended for physicians, nurses, nurse practitioners (NPs), physician assistants (PAs) involved in the care of high-risk patients with mild to moderate COVID-19 disease who are interested in setting up an infusion center for mAbs.
The goal of this activity is to provide physicians, nurses, and other clinicians with expert guidance on best practices based on the latest clinical and real-world use of Emergency Use Authorization (EUA) neutralizing antibody (NAb) infusions and to foster their appropriate use in the treatment of patients with mild to moderate COVID-19.
Upon completion of this activity, participants will: Have increased knowledge regarding the[LIST] [ITEM]Identification of patients who are candidates for NAbs[/LIST]Have greater competence related to [LIST] [ITEM]Appropriate follow-up for patients after NAb infusion[ITEM]Monitoring patients for reactions during NAb infusion[/LIST]Demonstrate greater confidence in their ability to [LIST] [ITEM]Collaborate with the interprofessional team to run a successful NAb infusion center[/LIST]
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO] [MEDSCAPE]
[BOLD]For Physicians[/BOLD] Medscape, LLC designates this live activity for a maximum of 1.0 [BOLD] [italic]AMA PRA Category 1 Credit(s)™[/italic] [/BOLD]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [BOLD]For Nurses[/BOLD] Awarded 1.0 contact hour(s) of nursing continuing professional development for RNs and APNs